GeneNews Ltd (GEN) - Medical Equipment - Deals and Alliances Profile
December 2018
46
About the Report
About the Report
Summary
GeneNews Ltd (GeneNews) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNews offers biomarkers for detect disease, stage diseases, monitor and progression and determine treatment, among others. The company's Sentinel Principle is used in early diagnosis, determining stage of disease, identifying responders and monitoring treatment compliance, among others. It provides screening tests in areas such as colon cancer, lung cancer, prostate cancer and breast cancer, among others. GeneNews is headquartered in Richmond Hill, Ontario, Canada.
GeneNews Ltd (GEN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
GeneNews Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
GeneNews Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
GeneNews Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
GeneNews Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
GeneNews Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
GeneNews Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
GeneNews Ltd, Medical Equipment, Deal Details 11
Venture Financing 11
GeneNews Raises USD0.2 Million in Venture Financing 11
Private Equity 12
GeneNews Raises USD1.5 Million in Private Placement of Convertible Securities 12
GEM Global Yield Fund to Invest USD4 Million in GeneNews 13
Partnerships 14
GeneNews Forms Joint Venture With Health Diagnostic Laboratory For US CLIA Lab 14
GeneNews Forms Joint Venture With Shanghai Biochip For Sentinel Centre For Personalized Medicine 15
Sphingotec Enters into Licensing Agreement with GeneNews 16
Equity Offering 17
GeneNews Raises USD1 Million in First Tranche of Private Placement of Units 17
GeneNews Raises USD10 Million in Financing 18
GeneNews Raises USD0.6 Million in Private Placement of Units 19
GeneNews Raises USD0.4 Million in First Tranche of Private Placement of Shares 20
GeneNews Raises USD0.9 Million in Non-Brokered Private Placement of Units 21
GeneNews to Raise up to USD2.4 Million in Private Placement of Units 22
GeneNews Raises USD1 Million upon Exercise of Warrants 23
GeneNews Raises USD7 Million in Private Placement of Shares 24
GeneNews Completes Private Placement Of Shares For USD 8 Million 25
GeneNews Completes Rights Offering Of Common Stock For USD 2.6 Million 26
Debt Offering 27
GeneNews to Raise USD0.5 Million in Private Placement of Notes 27
GeneNews Raises USD0.7 Million in Private Placement of 8% Debentures Due 2019 28
GeneNews Raises USD10 Million in Private Placement of 12% Notes Due 2017 29
Acquisition 30
GeneNews and Cobalt Healthcare Acquire 33% Stake in Innovative Diagnostic Labs from Health Diagnostic Labs for USD4 Million 30
GeneNews Ltd-Key Competitors 31
GeneNews Ltd-Key Employees 32
GeneNews Ltd-Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Joint Venture 33
Recent Developments 34
Financial Announcements 34
Aug 15, 2018: Genenews announces Q2 2018 results and provides progress update 34
May 16, 2018: GeneNews Announces Q1 2018 Results and Provides Progress Update 35
Apr 03, 2018: GeneNews Announces Q4 and Year End 2017 Financial Results & Provides Progress Update 36
Nov 15, 2017: GeneNews Announces Q3-2017 Financial Results & Provides Progress Update 37
Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update 38
May 11, 2017: GeneNews Announces Q1-2017 Financial Results & Provides Progress Update 39
Apr 03, 2017: GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results 41
Corporate Communications 42
Jul 12, 2018: GeneNews' Innovative Diagnostic Laboratory Appoints David Byram Chief Commercial Officer 42
Jun 29, 2018: GeneNews Announces Directors Election 43
Jun 30, 2017: GeneNews Announces Election of Directors 44
Other Significant Developments 45
Aug 15, 2018: GeneNews and LifeX partner to deliver proprietary "Liquid Biopsy" molecular diagnostics to health systems to detect cancer at earliest stages 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Figure
List of Figures
GeneNews Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
GeneNews Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
GeneNews Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
GeneNews Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
GeneNews Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
GeneNews Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
GeneNews Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
GeneNews Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List of Table
List of Tables
GeneNews Ltd, Medical Equipment, Key Facts, 2017 2
GeneNews Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
GeneNews Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
GeneNews Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
GeneNews Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
GeneNews Ltd, Deals By Market, 2012 to YTD 2018 9
GeneNews Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
GeneNews Raises USD0.2 Million in Venture Financing 11
GeneNews Raises USD1.5 Million in Private Placement of Convertible Securities 12
GEM Global Yield Fund to Invest USD4 Million in GeneNews 13
GeneNews Forms Joint Venture With Health Diagnostic Laboratory For US CLIA Lab 14
GeneNews Forms Joint Venture With Shanghai Biochip For Sentinel Centre For Personalized Medicine 15
Sphingotec Enters into Licensing Agreement with GeneNews 16
GeneNews Raises USD1 Million in First Tranche of Private Placement of Units 17
GeneNews Raises USD10 Million in Financing 18
GeneNews Raises USD0.6 Million in Private Placement of Units 19
GeneNews Raises USD0.4 Million in First Tranche of Private Placement of Shares 20
GeneNews Raises USD0.9 Million in Non-Brokered Private Placement of Units 21
GeneNews to Raise up to USD2.4 Million in Private Placement of Units 22
GeneNews Raises USD1 Million upon Exercise of Warrants 23
GeneNews Raises USD7 Million in Private Placement of Shares 24
GeneNews Completes Private Placement Of Shares For USD 8 Million 25
GeneNews Completes Rights Offering Of Common Stock For USD 2.6 Million 26
GeneNews to Raise USD0.5 Million in Private Placement of Notes 27
GeneNews Raises USD0.7 Million in Private Placement of 8% Debentures Due 2019 28
GeneNews Raises USD10 Million in Private Placement of 12% Notes Due 2017 29
GeneNews and Cobalt Healthcare Acquire 33% Stake in Innovative Diagnostic Labs from Health Diagnostic Labs for USD4 Million 30
GeneNews Ltd, Key Competitors 31
GeneNews Ltd, Key Employees 32
GeneNews Ltd, Other Locations 33
GeneNews Ltd, Joint Venture 33
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.